JP Morgan Private Capital, JP Morgan’s venture capital and growth equity investment team has held the final close of 270 Life Sciences Private Capital Fund I, above its $500m target. 

French mid-market private equity firm Parquest has held the final close of Parquest III with total limited partner commitments of €414m. Launched in 2022, the fund was oversubscribed and exceeded its initial target size of €400m.

InTandem Capital Partners, a middle-market private equity firm focused on healthcare services, has held the final closing of InTandem Capital Partners Fund III, at $715m, above its original target of $650m.

Partners Group has surpassed its target of $15bn in client commitments for its fifth direct private equity programme, which comprises commitments to the Partners Group Direct Equity V fund, as well as bespoke client solutions and open-ended funds that allocate to the same strategy.

Coller Capital, an independent investor dedicated exclusively to private market secondaries, has received regulatory approval to launch its first Luxembourg domiciled ‘SICAV’ fund, accessible to eligible private wealth investors outside of the US.

Harlan Capital Partners, a specialist in opportunistic private credit investments, has held the final close of Private Credit Harlan Special Opportunities Fund V and its associated vehicles, with approximately $130m in capital commitments.

Aquiline Capital Partners, a private investment firm focused on financial services and related technologies, has raised $2.3bn for its fifth private equity fund, Aquiline Financial Services Fund V, making it the firm’s largest fund to date.